Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients

Br J Haematol. 2024 Apr;204(4):1536-1539. doi: 10.1111/bjh.19330. Epub 2024 Feb 7.

Vincent Alcazer^{1

2}, Stéphane Morisset¹, Delphine Rea^{2

3}, Laurence Legros^{2

4}, Stéphanie Dulucq^{2

5}, Sandrine Hayette^{2

6}, Jean-Michel Cayuela^{2

7}, Françoise Huguet^{2

8}, François-Xavier Mahon^{2

9}, Gabriel Etienne^{2

9}, Franck E Nicolini^{1

2

10}

¹ Department of Haematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
² French Group of CML, Centre Léon Bérard, Lyon, France.
³ Department of Haematology, Hôpital Saint Louis, Paris, France.
⁴ Department of Haematology, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
⁵ Laboratory of Haematology, CHU de Bordeaux, Pessac, France.
⁶ Laboratory of Haematology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
⁷ Laboratory of Haematology, Hôpital Saint Louis, Paris, France.
⁸ Department of Haematology, Institut Universitaire du Cancer de Toulouse, CHU de Toulouse, France.
⁹ Department of Haematology, Institut Bergonié, Bordeaux, France.
¹⁰ Department of Clinical Haematology and INSERM U1052, CRCL, Centre Leon Bérard, Lyon, France.

No abstract available

Publication types